Twelve patients with non-insulin dependent diabetes mellitus (NIDDM) under secondary failure to sulfonylureas were studied to evaluate the effects of subcutaneous glucagon-like peptide-1(7-36)amide (GLP-1) on (a) the gastric emptying pattern of a solid meal (250 kcal) and (b) the glycemic and endocrine responses to this solid meal and an oral glucose tolerance test (OGTT, 300 kcal). 0.5 nmol/kg of GLP-1 or placebo were subcutaneously injected 20 min after meal ingestion. GLP-1 modified the pattern of gastric emptying by prolonging the time to reach maximal emptying velocity (lag period) which was followed by an acceleration in the post-lag period. The maximal emptying velocity and the emptying half-time remained unaltered. With both meals, GLP-1 diminished the postprandial glucose peak, and reduced the glycemic response during the first two postprandial hours by 54.5% (solid meal) and 32.7% (OGTT) (P < 0.05). GLP-1 markedly stimulated insulin secretion with an effect lasting for 105 min (solid meal) or 150 min (OGTT). The postprandial increase of plasma glucagon was abolished by GLP-1. GLP-1 diminished the postprandial release of pancreatic polypeptide. The initial and transient delay of gastric emptying, the enhancement of postprandial insulin release, and the inhibition of postprandial glucagon release were independent determinants (P < 0.002) of the postprandial glucose response after subcutaneous GLP-1. An inhibition of efferent vagal activity may contribute to the inhibitory effect of GLP-1 on gastric emptying.

This article has been cited by other articles:

				H. J. Woerle, M. Albrecht, R. Linke, S. Zschau, C. Neumann, M. Nicolaus, J. E. Gerich, B. Goke, and J. Schirra Impaired Hyperglycemia-Induced Delay in Gastric Emptying in Patients With Type 1 Diabetes Deficient for Islet Amyloid Polypeptide Diabetes Care, December 1, 2008; 31(12): 2325 - 2331. [Abstract] [Full Text] [PDF]

				A. Vinik, A. Nakave, and M. d. P. S. Chuecos A Break in the Brake Mechanism in Diabetes: A cause of postprandial hyperglycemia Diabetes Care, December 1, 2008; 31(12): 2410 - 2413. [Full Text] [PDF]

				P. B Higgins, J. R Fernandez, W T. Garvey, W. M Granger, and B. A Gower Entero-insular axis and postprandial insulin differences in African American and European American children Am. J. Clinical Nutrition, November 1, 2008; 88(5): 1277 - 1283. [Abstract] [Full Text] [PDF]

				C. N. Andrews, A. E. Bharucha, M. Camilleri, P. A. Low, B. Seide, D. Burton, K. Baxter, and A. R. Zinsmeister Nitrergic contribution to gastric relaxation induced by glucagon-like peptide-1 (GLP-1) in healthy adults Am J Physiol Gastrointest Liver Physiol, May 1, 2007; 292(5): G1359 - G1365. [Abstract] [Full Text] [PDF]

				T. J. Little, A. N. Pilichiewicz, A. Russo, L. Phillips, K. L. Jones, M. A. Nauck, J. Wishart, M. Horowitz, and C. Feinle-Bisset Effects of Intravenous Glucagon-Like Peptide-1 on Gastric Emptying and Intragastric Distribution in Healthy Subjects: Relationships with Postprandial Glycemic and Insulinemic Responses J. Clin. Endocrinol. Metab., May 1, 2006; 91(5): 1916 - 1923. [Abstract] [Full Text] [PDF]

				J Schirra, M Nicolaus, R Roggel, M Katschinski, M Storr, H J Woerle, and B Goke Endogenous glucagon-like peptide 1 controls endocrine pancreatic secretion and antro-pyloro-duodenal motility in humans Gut, February 1, 2006; 55(2): 243 - 251. [Abstract] [Full Text] [PDF]

				J. J. Meier, G. Kemmeries, J. J. Holst, and M. A. Nauck Erythromycin Antagonizes the Deceleration of Gastric Emptying by Glucagon-Like Peptide 1 and Unmasks Its Insulinotropic Effect in Healthy Subjects Diabetes, July 1, 2005; 54(7): 2212 - 2218. [Abstract] [Full Text] [PDF]

				S. Quddusi, T. P. Vahl, K. Hanson, R. L. Prigeon, and D. A. D'Alessio Differential Effects of Acute and Extended Infusions of Glucagon-Like Peptide-1 on First- and Second-Phase Insulin Secretion in Diabetic and Nondiabetic Humans Diabetes Care, March 1, 2003; 26(3): 791 - 798. [Abstract] [Full Text] [PDF]

				E. E. Daniel, M. Anvari, J. E. T. Fox-Threlkeld, and T. J. McDonald Local, exendin-(939)-insensitive, site of action of GLP-1 in canine ileum Am J Physiol Gastrointest Liver Physiol, September 1, 2002; 283(3): G595 - G602. [Abstract] [Full Text] [PDF]

				J Schirra, U Wank, R Arnold, B Goke, and M Katschinski Effects of glucagon-like peptide-1(7-36)amide on motility and sensation of the proximal stomach in humans Gut, March 1, 2002; 50(3): 341 - 348. [Abstract] [Full Text] [PDF]

				S. Delgado-Aros, D.-Y. Kim, D. D. Burton, G. M. Thomforde, D. Stephens, B. H. Brinkmann, A. Vella, and M. Camilleri Effect of GLP-1 on gastric volume, emptying, maximum volume ingested, and postprandial symptoms in humans Am J Physiol Gastrointest Liver Physiol, March 1, 2002; 282(3): G424 - G431. [Abstract] [Full Text] [PDF]

				P. J. Havel Peripheral Signals Conveying Metabolic Information to the Brain: Short-Term and Long-Term Regulation of Food Intake and Energy Homeostasis Experimental Biology and Medicine, December 1, 2001; 226(11): 963 - 977. [Abstract] [Full Text] [PDF]

				M. Samsom, L. A. Szarka, M. Camilleri, A. Vella, A. R. Zinsmeister, and R. A. Rizza Pramlintide, an amylin analog, selectively delays gastric emptying: potential role of vagal inhibition Am J Physiol Gastrointest Liver Physiol, June 1, 2000; 278(6): G946 - G951. [Abstract] [Full Text] [PDF]

				J Schirra, P Houck, U Wank, R Arnold, B Goke, and M Katschinski Effects of glucagon-like peptide-1(7-36)amide on antro-pyloro-duodenal motility in the interdigestive state and with duodenal lipid perfusion in humans Gut, May 1, 2000; 46(5): 622 - 631. [Abstract] [Full Text] [PDF]

				T. J. Kieffer and J. Francis Habener The Glucagon-Like Peptides Endocr. Rev., December 1, 1999; 20(6): 876 - 913. [Abstract] [Full Text]

				L. Hansen, C. F. Deacon, C. Ørskov, and J. J. Holst Glucagon-Like Peptide-1-(7-36)Amide Is Transformed to Glucagon-Like Peptide-1-(9-36)Amide by Dipeptidyl Peptidase IV in the Capillaries Supplying the L Cells of the Porcine Intestine Endocrinology, November 1, 1999; 140(11): 5356 - 5363. [Abstract] [Full Text]

				E. Naslund, J. Bogefors, S. Skogar, P. Gryback, H. Jacobsson, J. J. Holst, and P. M. Hellstrom GLP-1 slows solid gastric emptying and inhibits insulin, glucagon, and PYY release in humans Am J Physiol Regulatory Integrative Comp Physiol, September 1, 1999; 277(3): R910 - R916. [Abstract] [Full Text] [PDF]